Literature DB >> 31268980

Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.

Norifumi Harimoto1, Kouki Hoshino1, Ryo Muranushi1, Kei Hagiwara1, Takahiro Yamanaka1, Norihiro Ishii1, Mariko Tsukagoshi, Takamichi Igarashi1, Hiroshi Tanaka1, Akira Watanabe1, Norio Kubo1, Kenichirou Araki1, Yasuo Hosouchi2, Hideki Suzuki3, Kazuhisa Arakawa4, Keitarou Hirai5, Takaharu Fukazawa6, Hayato Ikota7, Ken Shirabe1.   

Abstract

OBJECTIVES: Understanding the effect of lymph node metastasis (LNM) on prognosis in pancreatic neuroendocrine neoplasm is helpful for surgery and follow-up. In this study, we investigated the significance of LNM in well-differentiated pancreatic neuroendocrine tumors (PanNETs) according to the World Health Organization 2017 classification.
METHODS: We retrospectively collected data for 95 consecutive patients with PanNET who underwent pancreatic resection with curative intent between January 2008 and December 2017 at 6 institutions. The clinicopathological factors were compared in patients with and without LNM, and prognostic factors were analyzed.
RESULTS: Lymph node metastasis was significantly associated with malignant potential of PanNET, such as larger tumor size, higher Ki-67 index, higher tumor grade, and higher incidence of lymphatic, vessel, and neural invasion. Lymph node metastasis was also associated with disease-free but not overall survival. Multivariate analysis identified NET grade 2 (G2) and G3 as independent risk factors for recurrence after curative resection.
CONCLUSIONS: World Health Organization 2017 classification was the most independent prognostic factor in patients with resectable well-differentiated PanNETs. Patients with G2 and higher-grade tumors require lymph node dissection to improve prognosis.

Entities:  

Mesh:

Year:  2019        PMID: 31268980     DOI: 10.1097/MPA.0000000000001355

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

Review 1.  Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.

Authors:  Masayuki Tanaka; Max Heckler; André L Mihaljevic; Pascal Probst; Ulla Klaiber; Ulrike Heger; Simon Schimmack; Markus W Büchler; Thilo Hackert
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

Review 2.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

Review 3.  Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

Authors:  Alfred King-Yin Lam; Hirotaka Ishida
Journal:  Histol Histopathol       Date:  2020-12-11       Impact factor: 2.303

4.  Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study.

Authors:  Hai-Bin Zhu; Pei Nie; Liu Jiang; Juan Hu; Xiao-Yan Zhang; Xiao-Ting Li; Ming Lu; Ying-Shi Sun
Journal:  Insights Imaging       Date:  2022-10-08

5.  Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors.

Authors:  Hao Zhou; Yajie Wang; Chuangen Guo; Xiaoshuang Li; Wenjing Cui; Zhongqiu Wang; Xiao Chen
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

6.  Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis.

Authors:  Lan Xiong; Youfan Jiang; Tianyang Hu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

7.  Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.

Authors:  Qing-Quan Tan; Xing Wang; Le Yang; Yong-Hua Chen; Chun-Lu Tan; Xiao-Mei Zhu; Neng-Wen Ke; Xu-Bao Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.